Divested
Sightera Biosciences has developed an AI drug discovery platform and therapeutic asset portfolio to accelerate the delivery of transformative therapies to patients worldwide
SpectaCell develops a fast, label-free single-cell analysis platform that helps biopharma measure how well immune therapies work, from early R&D through manufacturing
QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications
